These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 16246965)

  • 1. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.
    Ryan S; Taylor CT; McNicholas WT
    Circulation; 2005 Oct; 112(17):2660-7. PubMed ID: 16246965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.
    Ryan S; Taylor CT; McNicholas WT
    Am J Respir Crit Care Med; 2006 Oct; 174(7):824-30. PubMed ID: 16840748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation.
    Garvey JF; Taylor CT; McNicholas WT
    Eur Respir J; 2009 May; 33(5):1195-205. PubMed ID: 19407053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of intermittent hypoxia on the signal transduction pathways to inflammatory response and circadian clock regulation.
    Burioka N; Koyanagi S; Fukuoka Y; Okazaki F; Fujioka T; Kusunose N; Endo M; Suyama H; Chikumi H; Ohdo S; Shimizu E
    Life Sci; 2009 Aug; 85(9-10):372-8. PubMed ID: 19616563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndrome.
    Israel LP; Benharoch D; Gopas J; Goldbart AD
    Sleep; 2013 Dec; 36(12):1947-55. PubMed ID: 24293770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of cardiovascular damage in obstructive sleep apnea].
    Torre-Bouscoulet L; Castorena-Maldonado A; Sada-Ovalle I; Meza-Vargas MS
    Rev Invest Clin; 2008; 60(6):502-16. PubMed ID: 19378837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol selectively inhibits nuclear factor-κB activity by suppressing p38 mitogen-activated protein kinase signaling in human EA.hy926 endothelial cells during intermittent hypoxia/reoxygenation.
    Li D; Wang C; Li N; Zhang L
    Mol Med Rep; 2014 Apr; 9(4):1460-6. PubMed ID: 24535078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation.
    Ryan S; McNicholas WT; Taylor CT
    Biochem Biophys Res Commun; 2007 Apr; 355(3):728-33. PubMed ID: 17316568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats.
    Xu XM; Yao D; Cai XD; Ding C; Lin QD; Wang LX; Huang XY
    Sleep Breath; 2015 May; 19(2):677-84. PubMed ID: 25395264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.
    McNicholas WT
    Am J Respir Crit Care Med; 2009 Oct; 180(8):692-700. PubMed ID: 19628778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
    Ye J; Liu H; Li Y; Liu X; Zhu JM
    Chin Med J (Engl); 2007 Sep; 120(17):1482-6. PubMed ID: 17908454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
    Ryan S; Taylor CT; McNicholas WT
    Thorax; 2009 Jul; 64(7):631-6. PubMed ID: 19561283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue is influenced by hypoxia of obstructive sleep apnea syndrome independent of obesity.
    Thorn CE; Knight B; Pastel E; McCulloch LJ; Patel B; Shore AC; Kos K
    Diabetes Metab; 2017 Jun; 43(3):240-247. PubMed ID: 28131740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role inflammatory response genes in obstructive sleep apnea syndrome: a review.
    de Lima FF; Mazzotti DR; Tufik S; Bittencourt L
    Sleep Breath; 2016 Mar; 20(1):331-8. PubMed ID: 26201496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS.
    Ryan S; McNicholas WT
    Arch Physiol Biochem; 2008 Oct; 114(4):261-6. PubMed ID: 18946786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity.
    Peled N; Shitrit D; Bendayan D; Peled E; Kramer MR
    Respiration; 2007; 74(1):50-5. PubMed ID: 16954652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Intermittent Hypoxemia on Left Atrial Remodeling in Patients with Obstructive Sleep Apnea Syndrome.
    Chen YL; Chen YC; Wang HT; Chang YT; Fang YN; Hsueh S; Liu WH; Lin PT; Hsu PY; Su MC; Huang KT; Lin MC
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nCPAP therapy on cardiorespiratory outcomes in obstructive sleep apnea syndrome: compliance and technological advancements.
    Toraldo DM; De Nuccio F; Nicolardi G
    Expert Rev Respir Med; 2011 Feb; 5(1):41-7. PubMed ID: 21348585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease.
    Paschetta E; Belci P; Alisi A; Liccardo D; Cutrera R; Musso G; Nobili V
    Mediators Inflamm; 2015; 2015():815721. PubMed ID: 25873773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.